These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies. Taha DA; De Moor CH; Barrett DA; Gershkovich P Transl Res; 2014 Aug; 164(2):85-109. PubMed ID: 24530275 [TBL] [Abstract][Full Text] [Related]
24. Statin safety and drug interactions: clinical implications. Bottorff MB Am J Cardiol; 2006 Apr; 97(8A):27C-31C. PubMed ID: 16581325 [TBL] [Abstract][Full Text] [Related]
25. Statins, cardiovascular disease, and drug safety. Gotto AM Am J Cardiol; 2006 Apr; 97(8A):3C-5C. PubMed ID: 16581326 [TBL] [Abstract][Full Text] [Related]
26. Management of statin-intolerant patient. Arca M; Pigna G; Favoccia C Panminerva Med; 2012 Jun; 54(2):105-18. PubMed ID: 22525565 [TBL] [Abstract][Full Text] [Related]
27. Statins and cognitive side effects: what cardiologists need to know. Rojas-Fernandez C; Hudani Z; Bittner V Cardiol Clin; 2015 May; 33(2):245-56. PubMed ID: 25939297 [TBL] [Abstract][Full Text] [Related]
28. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy. Chang JT; Staffa JA; Parks M; Green L Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925 [TBL] [Abstract][Full Text] [Related]
29. Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials. Bangalore S; Fayyad R; Hovingh GK; Laskey R; Vogt L; DeMicco DA; Waters DD; Am J Cardiol; 2014 Jun; 113(12):2018-20. PubMed ID: 24793673 [TBL] [Abstract][Full Text] [Related]